Alcohol Hand Gel Use in Mbale Regional Referral Hospital: a Cost Effectiveness Evaluation (WardGel)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02435719|
Recruitment Status : Completed
First Posted : May 6, 2015
Last Update Posted : October 13, 2016
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
Ministry of Health through the National Medical Stores has supplied alcohol-based handgels to the different health facilities in Uganda for the health care providers to use during clinical care. However, constant stock-outs and or limited supplies remains the main constraint faced by the hospitals. Thus the handgels are generally used by a few of the senior health care providers.
The promotion of bedside, antiseptic handrubs largely contributes to the increase in compliance and sustained improvement of hand hygiene compliance reduces Health care acquired infections (HCAIs), but it is not yet established how cost- effective the intervention is in a a rural Ugandan hospital where funds are severely rationed and, which serves over 4 million people in over 15 districts in Uganda. An evaluation of an intervention's cost-effectiveness is a crucial factor in whether the government will be prepared to fund the intervention and sustain it.
This WardGel study thus aims to assess the cost-benefit of providing hand gel for all health care workers in Mbale Regional Referral Hospital.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||3626 participants|
|Official Title:||Effectiveness Evaluation of Alcohol Hand Gel Use in Mbale Regional Referral Hospital, Rural Eastern Uganda|
|Study Start Date :||October 2014|
|Actual Primary Completion Date :||May 2015|
|Actual Study Completion Date :||May 2015|
- Evidence of Hospital acquired infection confirmed clinically [ Time Frame: At least 48 hours after hospital admission or re-admission.Participants will be followed for the duration of hospital stay, an expected average of 5 days. ]Hospital acquired infection will be defined as new clinically diagnosed infection developed whilst an inpatient or within 2 days of discharge (for readmitted patients).
- Evidence of Hospital Acquired infection confirmed by laboratory investigations (CBC and C&S) [ Time Frame: At least 48 hours after admission or readmission.Participants will be followed for the duration of hospital stay, an expected average of 5 days. ]Participants will be followed for the duration of hospital stay, an expected average of 5 days.
- Hand hygiene compliance by health care providers based on the WHO's 5-moments of Hand hygiene [ Time Frame: during patient clinical care.participants will be observed during their clinical care practice, an expected average of 30 minutes per session ]participants will be observed during their clinical care practice, an expected average of 30 minutes per session
- cost-effectiveness of hand gel use by micro-economic assessment [ Time Frame: Additional period due to confirmed hospital acquired infection.Participants will be followed for the duration of hospital stay, an expected average of 5 days. ]Participants will be followed for the duration of hospital stay, an expected average of 5 days.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- Patients is admitted for at least 24 hours
- Any health care provider, including students
- Patients discharged before 24 hours
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02435719
|Mbale Regional Referral hospital|
|Principal Investigator:||Andrew Weeks, PhD||University of Liverpool|
|Principal Investigator:||James Ditai, MPH||Sanyu Africa Research Institute|
|Principal Investigator:||Benon Wanume, MMED (CP)||Mbale Regional Referral Hospital|
|Study Director:||Julian Abeso, MMED (Paed)||Mbale Regional Referral Hospital|
|Study Director:||Kyoko Inoue, MPH||Nagasaki University|
|Responsible Party:||Sanyu Africa Research Institute|
|Other Study ID Numbers:||
|First Posted:||May 6, 2015 Key Record Dates|
|Last Update Posted:||October 13, 2016|
|Last Verified:||October 2016|